Growth Metrics

Whitehawk Therapeutics (WHWK) Cash from Operations Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 60.84%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 85.14%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -15.72%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 74.39%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 3.23%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 158.60%
10 Whitehawk Therapeutics 312.26 Mn 189.22 Mn - -87.19%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -87.19%
Dec 31, 2025 -14.49%
Sep 30, 2025 1.97%
Jun 30, 2025 -478.32%
Mar 31, 2025 39.63%
Dec 31, 2024 -56.09%
Sep 30, 2024 -31.26%
Jun 30, 2024 45.36%
Mar 31, 2024 7.78%
Dec 31, 2023 14.73%
Sep 30, 2023 -45.83%
Jun 30, 2023 -56.32%
Mar 31, 2023 -9.76%
Dec 31, 2022 9.00%
Sep 30, 2022 52.83%
Jun 30, 2022 -236.58%
Mar 31, 2022 -283.80%
Dec 31, 2021 -279.48%
Sep 30, 2021 -10.11%
Jun 30, 2021 -130.95%
Mar 31, 2021 368.11%
Dec 31, 2020 32.68%
Sep 30, 2020 -231.25%
Jun 30, 2020 299.99%
Mar 31, 2020 56.60%
Dec 31, 2019 21.34%
Sep 30, 2019 23.45%
Jun 30, 2019 -139.25%
Mar 31, 2019 -39.37%
Dec 31, 2018 -34.09%
Sep 30, 2018 -54.81%
Jun 30, 2018 307.38%
Mar 31, 2018 -65.78%
Dec 31, 2017 -51.63%
Sep 30, 2017 16.81%
Jun 30, 2017 -59.18%
Mar 31, 2017 -1.45%
Dec 31, 2016 -110,876.32%
Sep 30, 2016 -126,199.01%
Jun 30, 2016 -30,010.82%
Mar 31, 2016 -195,908.45%
Dec 31, 2015 78.25%
Sep 30, 2015 -124.87%
Jun 30, 2015 -903.19%
Mar 31, 2015 -394.00%
Dec 31, 2014 -214.16%
Sep 30, 2014 79.06%
Jun 30, 2014 85.84%
Mar 31, 2014 78.96%
Dec 31, 2013 -411.73%
Sep 30, 2013 -107.27%
Jun 30, 2013 35.00%
Mar 31, 2013 65.61%
Dec 31, 2012 60.90%
Sep 30, 2012 -26.45%
Jun 30, 2012 7.25%
Mar 31, 2012 -144.13%
Dec 31, 2011 -463.20%
Sep 30, 2011 11.58%